These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35250176)

  • 1. Generation of Dual functional Nanobody-Nanoluciferase Fusion and its potential in Bioluminescence Enzyme Immunoassay for trace Glypican-3 in Serum.
    Yu S; Li Z; Li J; Zhao S; Wu S; Liu H; Bi X; Li D; Dong J; Duan S; Hammock BD
    Sens Actuators B Chem; 2021 Jun; 336():. PubMed ID: 35250176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemiluminescent Enzyme Immunoassay and Bioluminescent Enzyme Immunoassay for Tenuazonic Acid Mycotoxin by Exploitation of Nanobody and Nanobody-Nanoluciferase Fusion.
    Wang F; Li ZF; Yang YY; Wan DB; Vasylieva N; Zhang YQ; Cai J; Wang H; Shen YD; Xu ZL; Hammock BD
    Anal Chem; 2020 Sep; 92(17):11935-11942. PubMed ID: 32702970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-Step Ultrasensitive Bioluminescent Enzyme Immunoassay Based on Nanobody/Nanoluciferase Fusion for Detection of Aflatoxin B
    Ren W; Li Z; Xu Y; Wan D; Barnych B; Li Y; Tu Z; He Q; Fu J; Hammock BD
    J Agric Food Chem; 2019 May; 67(18):5221-5229. PubMed ID: 30883117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Ultrasensitive Bioluminescent Enzyme Immunoassay Based on Nanobody/Nanoluciferase Heptamer Fusion for the Detection of Tetrabromobisphenol A in Sediment.
    Li Z; Wang Y; Vasylieva N; Wan D; Yin Z; Dong J; Hammock BD
    Anal Chem; 2020 Jul; 92(14):10083-10090. PubMed ID: 32559059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobody-Nanoluciferase Fusion Protein-Enabled Immunoassay for Ochratoxin A in Coffee with Enhanced Specificity and Sensitivity.
    Bao K; Liu X; Liao Y; Liu Z; Cao H; Wu L; Chen Q
    Toxins (Basel); 2022 Oct; 14(10):. PubMed ID: 36287981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Non-Toxic Immunodetection of
    Wang F; Li ZF; Wan DB; Vasylieva N; Shen YD; Xu ZL; Yang JY; Gettemans J; Wang H; Hammock BD; Sun YM
    J Agric Food Chem; 2021 Apr; 69(16):4911-4917. PubMed ID: 33870684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein nanoscaffold enables programmable nanobody-luciferase immunoassembly for sensitive and simultaneous detection of aflatoxin B1 and ochratoxin A.
    Wu S; Xu J; Chen W; Wang F; Tan X; Zou X; Zhou W; Huang W; Zheng Y; Wang S; Yan S
    J Hazard Mater; 2024 Jan; 462():132701. PubMed ID: 37839380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.
    Yu JP; Xu XG; Ma RJ; Qin SN; Wang CR; Wang XB; Li M; Li MS; Ma Q; Xu WW
    J Clin Lab Anal; 2015 Mar; 29(2):85-93. PubMed ID: 24687454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma.
    Xia L; Teng Q; Chen Q; Zhang F
    Int J Nanomedicine; 2020; 15():2197-2205. PubMed ID: 32280214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobody-Based Assays for the Detection of Environmental and Agricultural Contaminants.
    Wang F; Wang H
    Methods Mol Biol; 2022; 2446():547-554. PubMed ID: 35157293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma.
    Zhang Q; Xiao Q; Lin Z; Ying X; Li Z; Lin JM
    Clin Biochem; 2010 Aug; 43(12):1003-8. PubMed ID: 20444424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a bioluminescent homogenous nanobody-based immunoassay for the detection of prostate-specific antigen (PSA).
    Baghdadi ME; Emamzadeh R; Nazari M; Michelini E
    Enzyme Microb Technol; 2024 Oct; 180():110474. PubMed ID: 38944901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.
    Jeon Y; Jang ES; Choi YS; Kim JW; Jeong SH
    Clin Mol Hepatol; 2016 Sep; 22(3):359-365. PubMed ID: 27729630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of nanobodies against hepatocellular carcinoma marker glypican-3.
    Wang W; Xu C; Wang H; Jiang C
    Mol Immunol; 2021 Mar; 131():13-22. PubMed ID: 33453658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a nanobody-alkaline phosphatase fusion and its application in an enzyme cascade-amplified immunoassay for colorimetric detection of alpha fetoprotein in human serum.
    Su B; Xu H; Xie G; Chen Q; Sun Z; Cao H; Liu X
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Dec; 262():120088. PubMed ID: 34167066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a nanobody-alkaline phosphatase heptamer fusion for ratiometric fluorescence immunodetection of trace alpha fetoprotein in serum.
    Su B; Bei Z; Pei H; Xie X; Sun Z; Chen Q; Cao H; Liu X
    Int J Biol Macromol; 2022 Mar; 201():507-515. PubMed ID: 35063488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Homogeneous Fluorescence Detection of AFP and GPC3 in Hepatocellular Carcinoma Clinical Samples Assisted by Enzyme-Free Catalytic Hairpin Assembly.
    Chen P; Jiang P; Lin Q; Zeng X; Liu T; Li M; Yuan Y; Song S; Zhang J; Huang J; Ying B; Chen J
    ACS Appl Mater Interfaces; 2022 Jun; 14(25):28697-28705. PubMed ID: 35699181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemiluminescence enzyme immunoassay based on magnetic nanoparticles for detection of hepatocellular carcinoma marker glypican-3.
    Zhang QY; Chen H; Lin Z; Lin JM
    J Pharm Anal; 2011 Aug; 1(3):166-174. PubMed ID: 29403695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of serum glypican-3 level in aided diagnosis of patients with primary hepatocellular carcinoma].
    Tang XY; Wang YC; Lu RQ; Guo L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):998-1002. PubMed ID: 32907292
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanobody medicated immunoassay for ultrasensitive detection of cancer biomarker alpha-fetoprotein.
    Chen J; He QH; Xu Y; Fu JH; Li YP; Tu Z; Wang D; Shu M; Qiu YL; Yang HW; Liu YY
    Talanta; 2016 Jan; 147():523-30. PubMed ID: 26592642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.